中基長壽科學(00767.HK)擬折價配售9285.58萬股 總籌3064.24萬港元
格隆匯6月16日丨中基長壽科學(00767.HK)發佈公告,2025年6月15日,公司與認購人訂立認購協議,據此,認購人已有條件地同意認購,而公司已有條件地同意配發及發行合共9285.58萬股認購股份,價格爲每股認購股份0.33港元。
假設於本公告日期至完成日期的間公司已發行股本概無變動,則認購股份相當於公司於本公告日期現有已發行股本的約16.99%,並相當於經配發及發行認購股份擴大後(須待認購事項完成後方可作實)的已發行股本的約14.52%。認購價較股份於6月13日(即緊接簽署認購協議前的最後交易日)在聯交所所報收市價每股0.5港元折讓約34.00%。認購股份將根據於股東周年大會授予董事的一般授權予以配發及發行,且發行認購股份無需獲得股東批準。公司將向上市委員會申請批準認購股份於聯交所上市及買賣。
認購事項籌集的所得款項總額將約爲3064.24萬港元,所得款項淨額將約爲3044.24萬港元,其中所得款項淨額的36.3%將用於香港中心的現有的長壽科學業務,所得款項淨額約13.2%將用於營運深圳長壽科學銷售渠道;所得款項淨額的17.5%將分配用於收回借貸及金融諮詢業務下策略夥伴已抵押房屋貸款涉及的法律專業費用及相關服務成本;而所得款項淨額約33.0%將分配用於集團一般營運資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.